High Point Advisor Group LLC Sorrento Therapeutics, Inc. Transaction History

High Point Advisor Group LLC

  • $1.76 Billion
  • Q2 2024

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Mar 26, 2024
BUY
N/A
2,215 Added 11.06%
22,250 $7,000
Q2 2022

Aug 15, 2022
SELL
$1.24 - $2.33 $496 - $932
-400 Reduced 1.96%
20,035 $51,000
Q3 2021

Nov 15, 2021
SELL
$7.41 - $10.99 $3,705 - $5,495
-500 Reduced 2.39%
20,435 $156,000
Q2 2021

Jul 29, 2021
SELL
$6.35 - $10.0 $24,765 - $39,000
-3,900 Reduced 15.7%
20,935 $203,000
Q1 2021

Apr 12, 2021
BUY
$7.03 - $16.51 $1,757 - $4,127
250 Added 1.02%
24,835 $187,000
Q4 2020

Feb 10, 2021
BUY
$5.76 - $11.95 $141,609 - $293,790
24,585 New
24,585 $396,000

Others Institutions Holding SRNE

# of Institutions
13
Shares Held
5.48M
Call Options Held
0
Put Options Held
0
View Full List

About Sorrento Therapeutics, Inc.

SRNE Quotes by TradingView
  • Ticker SRNE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 449,952,000
  • Market Cap $148M
  • Description
  • Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library an...
More about SRNE
Track This Portfolio

Track High Point Advisor Group LLC Portfolio

Follow High Point Advisor Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Point Advisor Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Point Advisor Group LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email